Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InVivo Therapeutics Holdings Corp NVIVQ

Healthcare Medical Devices
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by... see more

Recent & Breaking News (OTCPK:NVIVQ)

InVivo Therapeutics to Present at 2015 Tissue Engineering & Regenerative Medicine International Society World Congress

Business Wire August 31, 2015

Day 6 of the Shanghai Saga-Time To Make a Shopping List of Cheap Stocks to Buy (4 Stocks)

Accesswire August 27, 2015

InVivo Therapeutics to Present at the 17th Annual Spinal Research Network Meeting

Business Wire August 25, 2015

InVivo Therapeutics Announces Listing Transfer to Nasdaq Global Market

Business Wire August 24, 2015

InVivo Therapeutics Featured in Front Page Article in The Boston Globe

Business Wire August 24, 2015

InVivo Therapeutics Announces Enrollment of Fourth Patient in Pilot Spinal Cord Injury Trial

Business Wire August 20, 2015

InVivo Therapeutics' CEO and Chairman, Mark Perrin, Interviewed by Maria Bartiromo on FOX Business Network's "Mornings with Maria"

Business Wire August 13, 2015

InVivo Therapeutics Announces New Jersey's Cooper Neurological Institute as New Clinical Site for Neuro-Spinal Scaffold

Business Wire August 12, 2015

InVivo Therapeutics Announces Promotions and New Organizational Roles to Further Drive Market Development and Awareness of Spinal Cord Injury Innovation

Business Wire August 6, 2015

InVivo Therapeutics Reports 2015 Second Quarter Financial Results and Business Update

Business Wire August 5, 2015

InVivo Therapeutics Reports Significant Improvement of Second and Third Patients Implanted with Neuro-Spinal Scaffold

Business Wire July 6, 2015

InVivo Therapeutics to Present at Cantor Fitzgerald's Inaugural Healthcare Conference

Business Wire July 1, 2015

InVivo Therapeutics Announces Rutgers New Jersey Medical School as New Clinical Site for Neuro-Spinal Scaffold

Business Wire June 30, 2015

InVivo Therapeutics is Added to Russell Global, Russell 3000®, Russell 2000®, and Russell Microcap® Indexes

Business Wire June 29, 2015

InVivo Therapeutics to Present at the 33rd Annual Symposium of the National Neurotrauma Society

Business Wire June 23, 2015

InVivo Therapeutics Receives Notice of Allowance on Patent Covering Broader Compositions for Neuro-Spinal Scaffold and Neuro-Spinal Scaffold Plus Stem Cells

Business Wire June 22, 2015

InVivo Therapeutics Announces Posting of Management Presentation Recording from Annual Shareholders Meeting

Business Wire June 19, 2015

InVivo Therapeutics Co-Founder Dr. Robert Langer to Highlight InVivo Scientific Progress in Closing Keynote Address at the International Society for Stem Cell Research 2015 Annual Meeting

Business Wire June 18, 2015

InVivo Therapeutics Announces Appointment of Ann Merrifield as Lead Director

Business Wire June 16, 2015

InVivo Therapeutics Announces James Guest, M.D., Ph.D., Has Joined Scientific Advisory Board

Business Wire June 15, 2015